相关实验视频

Updated: Jun 23, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

向下一代测序分子分析及其在上腺皮层癌症的临床应用

Francesca Cioppi^1,2, Giulia Cantini^2,3,4, Tonino Ercolino⁵

¹Department of Experimental and Clinical Medicine, University of Florence, 50139 Florence, Italy.

European journal of endocrinology

|June 25, 2024

概括

目标下一代测序 (NGS) 识别了上腺皮质癌 (ACC) 中的关键基因突变. 某些突变组合,特别是NF1+TP53和Wnt/β-catenin+Rb/p53,显著影响患者的存活率,特别是在早期.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

上皮层癌 (ACC) 是一种罕见的癌症,预后可变.
瘤阶段和遗传变化影响了ACC的结果.
改善的预后有助于患者管理.

研究的目的:

使用简化目标下一代测序 (NGS) 面板来表征ACC突变特征.
为了将特定基因变异与整体存活率 (OS) 和无进展存活率 (PFS) 相关联.
评估NGS在ACC的预后评估中的实用性.

主要方法:

对30个冷的ACC瘤样本进行了回顾性分析.
定制的NGS面板针对关键基因 (例如CDKN2A,TP53,NF1).
整合86名TCGA系列患者,共计113名患者.

主要成果:

特定的基因突变组合显著影响PFS和OS.
NF1 + TP53和Wnt/β-catenin + Rb/p53突变是最有害的.
这些组合显示出统计学上显著的进展危险比率,特别是在低阶段的ACC.

结论:

简化向NGS是ACC体质遗传特征的实际第一步.
这种方法增强了预后评估.
研究结果表明,根据遗传特征,针对低阶段ACC患者进行量身定制的监测和治疗.

关键词:

在 ACC ACC ACC ACC ACC ACC ACC ACC ACC ACC ACC 这就是ACC-TCGA.遗传学遗传学遗传学是一个分子瘤学分子瘤学没有进展的生存率.常规分析常规分析身体突变特征身体突变特征有针对性的NGS.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...